The largest database of trusted experimental protocols

Etn enbrel

Manufactured by Pfizer
Sourced in United States

ETN—Enbrel is a laboratory equipment product designed for use in research and development settings. It is a recombinant human tumor necrosis factor receptor (TNFR) fusion protein that functions as a biologic response modifier. The core function of ETN—Enbrel is to aid in the study and investigation of immune system processes and inflammatory responses.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using etn enbrel

1

T-cell Activation and Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI-1640 Dutch modified (Gibco, Massachusetts, United States) culture medium, containing sodium bicarbonate and 20 mM HEPES, supplemented with penicillin/streptomycin (100 U/ml), sodium pyruvate (1 mM), glutamine/glutamax, and 10% human pooled serum (HPS, Radboudumc), was used in all experiments. After cell isolation, 2.5 × 104 cells/well were cultured in 96-well U-bottom plates and stimulated with Dynabeads® Human T-Activator CD3/CD28 (αCD3/CD28 beads, 1:5 of bead:cell ratio) (Gibco, Massachusetts, United States) in the presence of recombinant human (rh) IL-2 (rhIL-2, 100 U/ml) (Proleukin Prometheus Laboratories, California, United States). In some conditions, cultures were supplemented with rhTNFα (50 ng/ml, R&D, Minnesota, United States), or TNFα inhibitors etanercept (5 μg/ml; ETN—Enbrel, Pfizer, New York, United States), or TNFR2 agonist (2.5 μg/ml, Clone MR2-1, Hycult Biotech, Uden, the Netherlands). To examine the effect of a pharmaceutical inhibitor, tofacitinib (0.112 μM, Pfizer, New York, United States), PKC inhibitor Sotrastaurin (1 μM), Lck inhibitor A420983 (1 μM), or p38α/β kinase inhibitor UR13870 (10 μM) was pre-incubated with the FACS-sorted cells for 30 min before the addition of any stimulus. In some cases, cells were stimulated with PMA (12.5 ng/ml) and ionomycin (500 ng/ml) for 20 h.
+ Open protocol
+ Expand
2

Treg Cell Activation and Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
FACS-sorted CD4+CD25high Treg were cultured for 7 days with IL-2 (200 U/mL) containing medium alone as non-stimulated control, or together with different combinations of CD28 superagonist (CD28-SA, 1 µg/mL, Clone ANC28.1/5D10, Cat# 177-820, preservative free; Ancell, Bayport, MN, USA), rapamycin (Rap, 1 µM, Sigma-Aldrich, St. Louis, MO, USA), and TNFR2 agonist mAb (2.5 µg/mL, Clone MR2-1, Hycult, Netherlands). Exogenous recombinant human (rh) TNFα (50 ng/mL, R&D, Minneapolis, MN, USA) was used to replace TNFR2 agonist where indicated. Etanercept (10 µg/mL, ETN-Enbrel®, Pfizer) was added to cell culture for the depletion of TNFα. Cells were harvested at day 7 of culture for phenotypic analysis, and culture supernatants were collected and stored for the subsequent cytokine analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!